Huizinga Robert Bindert 4
4 · Aurinia Pharmaceuticals Inc. · Filed Sep 14, 2021
Insider Transaction Report
Form 4
Huizinga Robert Bindert
EVP of Research
Transactions
- Sale
Common Stock
2021-09-10$19.83/sh−5,000$99,150→ 133,592 total - Sale
Common Stock
2021-09-10$19.76/sh−5,000$98,800→ 128,592 total - Sale
Common Stock
2021-09-14$21.75/sh−22,500$489,375→ 106,092 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.